These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26507805)

  • 1. Intrathecal CD4(+) and CD8(+) T-cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients.
    van Nierop GP; Janssen M; Mitterreiter JG; van de Vijver DA; de Swart RL; Haagmans BL; Verjans GM; Hintzen RQ
    Eur J Immunol; 2016 Feb; 46(2):347-53. PubMed ID: 26507805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins.
    van Nierop GP; Mautner J; Mitterreiter JG; Hintzen RQ; Verjans GM
    Mult Scler; 2016 Mar; 22(3):279-91. PubMed ID: 26041797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients.
    van Nierop GP; van Luijn MM; Michels SS; Melief MJ; Janssen M; Langerak AW; Ouwendijk WJD; Hintzen RQ; Verjans GMGM
    Acta Neuropathol; 2017 Sep; 134(3):383-401. PubMed ID: 28624961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells.
    Lossius A; Johansen JN; Vartdal F; Robins H; Jūratė Šaltytė B; Holmøy T; Olweus J
    Eur J Immunol; 2014 Nov; 44(11):3439-52. PubMed ID: 25103993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human CD8+ TCR-alpha beta(+) and TCR-gamma delta(+) cells modulate autologous autoreactive neuroantigen-specific CD4+ T-cells by different mechanisms.
    Correale J; Rojany M; Weiner LP
    J Neuroimmunol; 1997 Dec; 80(1-2):47-64. PubMed ID: 9413259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein.
    Holmøy T; Kvale EØ; Vartdal F
    J Neurovirol; 2004 Oct; 10(5):278-83. PubMed ID: 15385250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study.
    Van der Aa A; Hellings N; Medaer R; Gelin G; Palmers Y; Raus J; Stinissen P
    Clin Exp Immunol; 2003 Jan; 131(1):155-68. PubMed ID: 12519400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones.
    van Binnendijk RS; Poelen MC; de Vries P; Voorma HO; Osterhaus AD; Uytdehaag FG
    J Immunol; 1989 Apr; 142(8):2847-54. PubMed ID: 2467943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis.
    Zang YC; Li S; Rivera VM; Hong J; Robinson RR; Breitbach WT; Killian J; Zhang JZ
    J Immunol; 2004 Apr; 172(8):5120-7. PubMed ID: 15067096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma.
    Olsson T; Zhi WW; Höjeberg B; Kostulas V; Jiang YP; Anderson G; Ekre HP; Link H
    J Clin Invest; 1990 Sep; 86(3):981-5. PubMed ID: 1697609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific CD8(+) T-lymphocytes control dissemination of measles virus.
    de Vries RD; Yüksel S; Osterhaus AD; de Swart RL
    Eur J Immunol; 2010 Feb; 40(2):388-95. PubMed ID: 19950186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.
    Zafranskaya M; Oschmann P; Engel R; Weishaupt A; van Noort JM; Jomaa H; Eberl M
    Immunology; 2007 May; 121(1):29-39. PubMed ID: 17239199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines.
    Meij P; Bloemena E; Palmen N; Brink A; Vervoort MB; Meijer CJ; Middeldorp JM
    Cell Immunol; 2001 Feb; 208(1):25-33. PubMed ID: 11277616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
    Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
    Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-reactive and autoreactive T cells are accumulated in cerebrospinal fluid in multiple sclerosis.
    Link H; Sun JB; Wang Z; Xu Z; Löve A; Fredrikson S; Olsson T
    J Neuroimmunol; 1992 May; 38(1-2):63-73. PubMed ID: 1374425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis.
    Harp CT; Lovett-Racke AE; Racke MK; Frohman EM; Monson NL
    Clin Immunol; 2008 Sep; 128(3):382-91. PubMed ID: 18599355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity.
    Gudgeon NH; Taylor GS; Long HM; Haigh TA; Rickinson AB
    J Virol; 2005 May; 79(9):5477-88. PubMed ID: 15827162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new clinically relevant approach to expand myelin specific T cells.
    Arbour N; Lapointe R; Saikali P; McCrea E; Regen T; Antel JP
    J Immunol Methods; 2006 Mar; 310(1-2):53-61. PubMed ID: 16464465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.